FEATUREDLatestNationalNewsTODAY'S STORIESTOP STORIES

Delhi HC Refuses To Ban Clinical Trial Of Children’s Covid Vaccine

Delhi HC refuses to ban clinical trial of Children’s Corona Vaccine, Center-DCGI issued notice.

Preparations have also begun to save children in the country amid the second havoc wave of Corona virus infection. Under this, the country will soon get the Corona vaccine for children, because the vaccine is ready for trial.

At the same time, in the latest development, the Delhi HC also filed a complaint with the Central Government with the Drug Controller General of India on a PIL challenging the DCGI for the Phase 2-3 trials of Covaxin for children aged 2-18 years.

Notice has been issued. Along with this, the Delhi High Court has issued an interim stay on the clinical trial refusing to issue a notice.

Let us tell you that on Tuesday the member of NITI Aayog, Dr. VK Paul, gave big news about the corona vaccine for 2-18 year olds.

According to Dr. VK Paul, the Drug Controller General of India (DCGI) has been approved for clinical trials of covaxine on children aged 2–18 years. He has also informed that its clinical trial will begin in 10 to 12 days.

Dr. VK Paul has also informed that the Drug Controller General of India has given its approval by the Drug Controller General of India (DCGI) for the clinical trial of Covaxine on children aged 2 to 18 years.

Dr. VK Paul, Member, NITI Aayog, said that for the treatment of Corona, we will investigate the DRDO drug in the Covid-19 National Task Force and decide on its inclusion in the Corona Treatment Protocol.

Delhi HC refuses to ban clinical trial: The Drug Controller General of India has approved its emergency use.

Explain that experts are constantly claiming that during the third wave, children in the country will be exposed to a large number of corona virus infections.

In Delhi alone, 4000 beds are being prepared in many big hospitals including AIIMS, so that children can be admitted and treated here if they suffer.

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2023 DNN All Rights Reserved